Your browser doesn't support javascript.
loading
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
Ghobadian, Ala; Mokhtari, Saba; Shariati, Behnam; Kamalzadeh, Leila; Shati, Mohsen; Eftekhar Ardebili, Mehrdad; Yarahmadi, Masoomeh; Shalbafan, Mohammadreza.
Affiliation
  • Ghobadian A; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mokhtari S; Department of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Shariati B; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Kamalzadeh L; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Shati M; Mental Health Research Center (MHRC), School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran.
  • Eftekhar Ardebili M; Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • Yarahmadi M; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Shalbafan M; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
BMC Pharmacol Toxicol ; 23(1): 73, 2022 09 27.
Article in En | MEDLINE | ID: mdl-36167636

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sertraline / Obsessive-Compulsive Disorder Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: BMC Pharmacol Toxicol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sertraline / Obsessive-Compulsive Disorder Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: BMC Pharmacol Toxicol Year: 2022 Document type: Article Affiliation country: Country of publication: